Filing Details
- Accession Number:
- 0001209191-18-013961
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-27 16:50:48
- Reporting Period:
- 2018-02-23
- Accepted Time:
- 2018-02-27 16:50:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920465 | La Jolla Pharmaceutical Co | LJPC | Biological Products, (No Disgnostic Substances) (2836) | 330361285 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1178579 | C Kevin Tang | 4747 Executive Drive, Suite 510 San Diego CA 92121 | Yes | No | Yes | No | |
| 1191935 | Tang Capital Partners Lp | 4747 Executive Drive, Suite 510 San Diego CA 92121 | No | No | Yes | No | |
| 1232621 | Tang Capital Management Llc | 4747 Executive Drive, Suite 510 San Diego CA 92121 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-23 | 10,000 | $31.54 | 3,450,419 | No | 4 | P | Indirect | By LP |
| Common Stock | Acquisiton | 2018-02-23 | 10,000 | $31.94 | 3,460,419 | No | 4 | P | Indirect | By LP |
| Common Stock | Acquisiton | 2018-02-23 | 10,000 | $32.42 | 3,470,419 | No | 4 | P | Indirect | By LP |
| Common Stock | Acquisiton | 2018-02-23 | 20,000 | $32.58 | 3,490,419 | No | 4 | P | Indirect | By LP |
| Common Stock | Acquisiton | 2018-02-23 | 10,000 | $32.30 | 3,500,419 | No | 4 | P | Indirect | By LP |
| Common Stock | Acquisiton | 2018-02-26 | 10,000 | $32.92 | 3,510,419 | No | 4 | P | Indirect | By LP |
| Common Stock | Acquisiton | 2018-02-26 | 10,000 | $32.48 | 3,520,419 | No | 4 | P | Indirect | By LP |
| Common Stock | Acquisiton | 2018-02-26 | 1,000 | $32.50 | 3,521,419 | No | 4 | P | Indirect | By LP |
| Common Stock | Acquisiton | 2018-02-27 | 9,000 | $32.70 | 3,530,419 | No | 4 | P | Indirect | By LP |
| Common Stock | Acquisiton | 2018-02-27 | 10,000 | $32.17 | 3,540,419 | No | 4 | P | Indirect | By LP |
| Common Stock | Acquisiton | 2018-02-27 | 10,000 | $30.57 | 3,550,419 | No | 4 | P | Indirect | By LP |
| Common Stock | Acquisiton | 2018-02-27 | 10,000 | $30.88 | 3,560,419 | No | 4 | P | Indirect | By LP |
| Common Stock | Acquisiton | 2018-02-27 | 10,000 | $30.87 | 3,570,419 | No | 4 | P | Indirect | By LP |
| Common Stock | Acquisiton | 2018-02-27 | 10,000 | $30.69 | 3,580,419 | No | 4 | P | Indirect | By LP |
| Common Stock | Acquisiton | 2018-02-27 | 10,000 | $30.60 | 3,590,419 | No | 4 | P | Indirect | By LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By LP |
| No | 4 | P | Indirect | By LP |
| No | 4 | P | Indirect | By LP |
| No | 4 | P | Indirect | By LP |
| No | 4 | P | Indirect | By LP |
| No | 4 | P | Indirect | By LP |
| No | 4 | P | Indirect | By LP |
| No | 4 | P | Indirect | By LP |
| No | 4 | P | Indirect | By LP |
| No | 4 | P | Indirect | By LP |
| No | 4 | P | Indirect | By LP |
| No | 4 | P | Indirect | By LP |
| No | 4 | P | Indirect | By LP |
| No | 4 | P | Indirect | By LP |
| No | 4 | P | Indirect | By LP |
Footnotes
- The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin C. Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP.
Billionaire Hedge Funds
